Integral Derivatives’s Barclays BCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-13,876
Closed -$140K – 1131
2017
Q2
$140K Buy
+13,876
New +$142K ﹤0.01% 1020
2017
Q1
– Sell
-20,889
Closed -$217K – 1164
2016
Q4
$217K Sell
20,889
-3,181
-13% -$30K ﹤0.01% 982
2016
Q3
$197K Buy
+24,070
New +$190K ﹤0.01% 896
2015
Q1
– Sell
-29,796
Closed -$416K – 1102
2014
Q4
$416K Buy
+29,796
New +$409K 0.01% 973
2014
Q3
– Sell
-11,779
Closed -$159K – 1397
2014
Q2
$159K Hold
11,779
– – ﹤0.01% 1247
2014
Q1
$171K Sell
11,779
-37,391
-76% -$599K ﹤0.01% 1195
2013
Q4
$825K Buy
+49,170
New +$779K 0.01% 855

Other funds holding BCS

Integral Derivatives's BCS Position: Q3 2017 in Review

Integral Derivatives sold out of Barclays (BCS) in Q3 2017, closing a stake of 12,374 shares — an estimated $125K sold.

Integral Derivatives first reported a position in BCS in Q2 2014 and held it in 3 quarters. The position peaked at $286K in Q4 2014. 232 funds tracked by Wall St. Rank hold BCS as of Q3 2017.

  • Integral Derivatives reported no remaining Barclays position as of Q3 2017 after selling out during the quarter.
  • Integral Derivatives sold 12,374 Barclays shares in Q3 2017, an estimated $125K.
  • Integral Derivatives first reported a position in Barclays in Q2 2014 and held it in 3 quarters.
  • Integral Derivatives's Barclays position peaked at $286K in Q4 2014.
  • 232 funds tracked by Wall St. Rank held Barclays as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.